2020 The Year Of RAP, page-470

Don't forget the not so small elephant in the room...extract from the OSA announcement from 30 Sept. last year below as a reminder.

“We achieved excellent performance previously during our in-laboratory sleep studies and it is
great to see the same high levels of performance replicated in our intended use setting, in
peoples’ homes,” said Tony Keating, CEO and Managing Director of ResApp. “Nearly one billion
people suffer from sleep apnoea and 80% of those with moderate or severe sleep apnoea remain
undiagnosed. By delivering a highly scalable, low cost smartphone app for OSA screening we have
a huge opportunity to reduce the health and economic impact of undiagnosed OSA. We will now
move forward into the regulatory submission and commercialisation phases of this exciting
project.”